Program Summary

The proposed research project should be a new project intended to support clinical and translational oncology research.  
Projects should account for the 1-year term of the grant and the funding allocation provided and will be assessed based on both academic merit and feasibility.
The funding decision will be made by the MOASC Board of Directors. 

Applicant Eligibility Criteria: 
•    Have an MD or DO degree with an intent to practice clinical oncology. 
•    Have initiated or completed an ACGME-accredited fellowship program in hematology and/or oncology. 
•    Be no more than 7 years beyond completion of fellowship training. 
•    Practice at a Southern California institution for the full duration of the award (1 year). 

Application Details:
•    The amount of funding available for this grant is $25,000. 
•    One grant will be awarded. 
•    The duration allows for a 1-year term. 
•    The funding provided is intended to support clinical and translational work to advance the treatment approach for patients with cancer. 

Application Dates

Submission Deadline:                         Friday, December 20, 2024
Decision Date:                                    Monday, February 3, 2025 
Present at Annual Meeting                 Saturday, March 22, 2025
Start of Grant Term:                            Tuesday, July 1, 2025
End of Grant Term:                             Tuesday, June 30, 2026

Please e-mail the entire grant application as one PDF document to [email protected] by December 20, 2024.

*Supported by a grant from AVEO Oncology (“AVEO”), an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer.